Answers are grounded in this paper and cite their sources.
Autoimmune diseases (ADs) affect 5–10% of the population, with 80–85% of diagnosed patients being women. This pronounced sexual dimorphism is influenced by genetic factors (X chromosome), fluctuations in sex hormones, and unique immunological changes occurring during pregnancy and the postpartum period. These factors contribute to women’s distinct susceptibility to autoimmune disorders and may influence their clinical course. This narrative review critically evaluates the immunological, hormonal, and pregnancy-related factors contributing to female autoimmunity with particular emphasis on the bidirectional interactions between pregnancy-induced immunomodulation and maternal autoimmunity. By contrasting four distinct diseases systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), multiple sclerosis (MS), and type 1 diabetes (T1D), representing different immune paradigms (type 1 T helper (Th1) vs. type 2 T helper (Th2), systemic vs. organ-specific), we aim to analyze how mechanisms like placental tolerance and fetal microchimerism specifically shape disease trajectories and obstetric outcomes, contextualized within the evolutionary pregnancy compensation hypothesis. A literature review (PubMed, Scopus, Web of Science) was conducted to synthesize clinical and molecular evidence. The mechanisms of placental immune tolerance, the phenomenon of fetal microchimerism, and the evolutionary pregnancy compensation hypothesis were analyzed. Selected autoimmune diseases were used to illustrate disease-specific manifestations of these mechanisms. The literature highlights the complex interplay between genetic, hormonal and immunological factors in female autoimmunity. Estrogens, progesterone, androgens and prolactin exert distinct immunomodulatory effects influencing immune cell activity, cytokine production and immune tolerance. Fetal microchimerism (FMc) may have long-term immunological consequences, potentially contributing to either immune regulation or autoimmune pathology. These mechanisms may help explain the variable effects of pregnancy on autoimmune disease activity and obstetric outcomes, as illustrated by SLE, RA, MS, and T1D. The pregnancy compensation hypothesis offers an additional evolutionary perspective. However, it remains speculative and requires further investigation. Pregnancy induces complex, disease-specific immunomodulatory changes. Instead of one-size-fits-all regimens, caring for pregnant women with autoimmune disease requires a highly personalized and multidisciplinary approach based on risk stratification and monitoring of specific biomarkers. Current evidence suggests an intriguing influence of molecular changes on the course of autoimmunity; however, a full understanding of these mechanisms requires further, targeted research. Interactions between gender, pregnancy and the clinical dynamics of autoimmune diseases in women. Th1 - T helper 1 cells, Th2 - T helper 2 cells, Treg - Regulatory T cells, IL-10 - Interleukin-10, TGF-β - Transforming Growth Factor Beta, PD-L1 - Programmed Death-Ligand 1, TGF-β1 - Transforming Growth Factor Beta 1, FMc - Fetal Microchimerism
No takes yet. Share an insight, caveat, or question.
Pelczar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: